Zoledronic acid as adjunct to androgen deprivation therapy reduces bone loss in men with prostate cancer

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [41] Complications of Androgen Deprivation Therapy in Men With Prostate Cancer
    Patil, Tejas
    Bernard, Brandon
    ONCOLOGY-NEW YORK, 2018, 32 (09): : 470 - 475
  • [42] The effect of risedronate to prevent bone loss in men under androgen-deprivation therapy for prostate cancer.
    Ishizaka, K
    Machida, T
    Ozeki, Z
    Kobayashi, S
    Mizuno, Y
    Masuda, S
    Kamai, T
    Arai, K
    Honda, M
    Yoshida, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S309 - S309
  • [43] Complications of androgen deprivation therapy in men with prostate cancer
    Chen A.C.
    Petrylak D.P.
    Current Oncology Reports, 2004, 6 (3) : 209 - 215
  • [44] Recommendations for use of zoledronic acid (Z) for prevention and treatment of osteoporosis in men on androgen deprivation therapy (ADT) for prostate cancer (PC)
    Pandya, M. B.
    Broderick, W.
    Campbell, S. C.
    Garewal, H.
    Friedman, N.
    Moritz, T.
    Reda, D.
    Bhoopalam, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer
    Ryan, Christopher W.
    Huo, Dezheng
    Demers, Laurence M.
    Beer, Tomasz M.
    Lacerna, Leo V.
    JOURNAL OF UROLOGY, 2006, 176 (03): : 972 - 978
  • [46] Nursing Considerations for Androgen Deprivation Therapy and Bone Health in Men Affected by Prostate Cancer
    Cope, Diane G.
    SEMINARS IN ONCOLOGY NURSING, 2022, 38 (02)
  • [47] BONE HEALTH IN MEN WITH PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY: AUDIT AND SERVICE DEVELOPMENT
    Sheng, Ziyan
    Srivastava, Puneet
    Shah, Jyoti
    Yaqub, Shahid
    Laxminarayan, Ramasharan
    Ugur, Antonia
    Williams, Simon
    Broadhurst, Sarah
    Tipper, Judith
    Haynes, Charlotte
    Hui, Michelle
    RHEUMATOLOGY, 2023, 62
  • [48] Bone mineral density in prostate cancer patients undergoing initial androgen deprivation therapy: Zoledronic acid vs. placebo
    Israeli, RS
    Rosenberg, S
    Saltzstein, D
    Gottesman, JE
    Goldstein, HB
    Hull, G
    Tran, D
    Warsi, G
    Lacema, LV
    JOURNAL OF UROLOGY, 2006, 175 (04): : 134 - 134
  • [49] Back to Basics: Addressing Bone Health in Men with Prostate Cancer on Androgen Deprivation Therapy
    Morgans, Alicia K.
    Higano, Celestia S.
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (05): : 562 - 564
  • [50] Bone mineral density in Nigerian men on androgen deprivation therapy for advanced prostate cancer
    Olufemi Olayide Ojewuyi
    Stephen Odunayo Ikuerowo
    Emmanuel Ajibola Jeje
    Oladipo Adeboluji Adewole
    Abimbola Ayodeji Abolarinwa
    Olufunmilade Akinfolarin Omisanjo
    African Journal of Urology, 2020, 26
12345